The US Food and Drug Administration (FDA) has updated its guidance on biocompatibility issues medical device sponsors should consider in their premarket submissions. This is the second time the agency ...

Medical device manufacturers use cytotoxicity testing to help prove that devices that come into contact with the human body are biocompatible. Testing results are critical for gaining market access, ...

The US Food and Drug Administration (FDA) has published a chemical dataset that analytical laboratories can use to demonstrate they can detect chemicals that may not be biocompatible for use in ...

NEW YORK, NY, UNITED STATES, January 26, 2026 / EINPresswire.com / — STEMart, a US-based provider of comprehensive services for all phases of medical device development, has announced the expansion of ...

The evolution of medical-grade thermoplastic polyurethanes (TPUs) continues to reshape possibilities for device manufacturers seeking materials that combine flexibility, durability and ...

Surface modification of medical devices allows manufacturers to maintain the mechanical properties of materials while adding specific functionalities at biological interfaces. This optimization is ...

Researchers have developed a surface treatment that could improve the body’s acceptance of medical devices such as joint replacements and stents, according to a Chemistry World report. The method ...

STEMart announces the expansion of its genetic toxicology capabilities with the In Vivo Rat Micronucleus Test services. NEW YORK, NY, UNITED STATES, January 26, 2026 ...